Important checkpoints in CRC are lymphocyte-activation gene 3 (LAG3), CTLA4, T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) and PDL1, which control tumor growth and progression [16]. The gene discussed is CTLA4; the disease is neoplasm.